Is endogenous carboxyhaemoglobin level a useful biomarker of clinical course and prognosis in COVID-19 patients?

被引:8
|
作者
Kerget, Bugra [1 ]
Kerget, Ferhan [2 ]
Kocak, Abdullah Osman [3 ]
Akbas, Ilker [4 ]
Araz, Omer [1 ]
Ucar, Elif Yilmazel [1 ]
Akgun, Metin [1 ]
机构
[1] Ataturk Univ, Sch Med, Dept Pulm Dis, Erzurum, Turkey
[2] Hlth Sci Univ, Erzurum Reg Educ & Res Hosp, Dept Infect Dis & Clin Microbiol, Erzurum, Turkey
[3] Ataturk Univ, Sch Med, Dept Emergency Med, Erzurum, Turkey
[4] Bingol State Hosp, Dept Emergency Med, Bingol, Turkey
关键词
CARBON-MONOXIDE PRODUCTION;
D O I
10.1111/ijcp.14680
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective SARS-CoV-2 has caused nearly 4 million confirmed cases of COVID-19 worldwide in the approximately 4 months since it emerged in Wuhan, China in December 2019. Comorbidities increase morbidity and mortality in COVID-19, and many laboratory parameters have been associated with mortality. The aim of the present study was to identify the relationship between endogenous carboxyhaemoglobin (COHb) level and the clinical course and prognosis of COVID-19. Methods The study included 48 non-smokers or ex-smokers aged 18 years or older who presented to the emergency department, were diagnosed with COVID-19 by real-time PCR analysis of nasopharyngeal swab sample and were treated in the pulmonary diseases ward of the Ataturk University hospital after 24 March 2020 and 15 April 2020. The patients' laboratory parameters and demographic data were analysed retrospectively. Results Prothrombin time and C-reactive protein (CRP), troponin-I, and D-dimer levels decreased in COVID-19 patients during follow-up (P = .024, P = .001, P = .001, P = .001), while PaO2/FiO(2) ratio and COHb increased (P = .002, P = .001). COHb level at admission was significantly lower in patients who developed macrophage activation syndrome (MAS), acute respiratory distress syndrome (ARDS), and those who died compared with the other patients (P = .002, P = .001). COHb level on day 5 of treatment was significantly higher in patients with ARDS and patients who died (P = .001, P = .001). Significant correlations were detected between COHb level and CRP (r=-0.425, P = .001), ferritin (r = -.395, P = .001) and PaO2/FiO(2) ratio (r = .431, P = .001). Conclusions COHb level may be an easily accessible biomarker that guides early follow-up and treatment planning to avoid ARDS, MAS and mortality in COVID-19.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis
    Pieri, Massimo
    Ciotti, Marco
    Nuccetelli, Marzia
    Perrone, Marco Alfonso
    Calio, Maria Teresa
    Lia, Maria Stella
    Minieri, Marilena
    Bernardini, Sergio
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 95
  • [3] Endogenous Carboxyhemoglobin Concentrations in Predicting Prognosis of Patients with COVID-19 Pneumonia
    Demir, Mehmet C.
    Akpinar, Guleser
    Sultanoglu, Hasan
    Yildiz-Gulhan, Pinar
    Caliskan, Emel
    Guclu, Derya
    Karakoyun, Salih
    Ince, Nevin
    CLINICAL LABORATORY, 2021, 67 (05) : 1273 - 1279
  • [4] Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients
    Park, Mikyoung
    Hur, Mina
    Kim, Hanah
    Lee, Chae Hoon
    Lee, Jong Ho
    Kim, Hyung Woo
    Nam, Minjeong
    Lee, Seungho
    DIAGNOSTICS, 2023, 13 (02)
  • [5] Serum biomarker panel for disease severity and prognosis in patients with COVID-19
    Li, Jing
    Tang, Mingyang
    Liu, Didi
    Xie, Zongyu
    Wang, Fengchao
    Yang, Yanqing
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (02)
  • [6] Hypercalcemia as a Biomarker of Poor Prognosis in Frail Elderly Patients with COVID-19
    D. Pamart
    M. Otekpo
    M. Asfar
    G. Duval
    J. Gautier
    Cédric Annweiler
    The journal of nutrition, health & aging, 2021, 25 : 1140 - 1144
  • [7] Hypercalcemia as a Biomarker of Poor Prognosis in Frail Elderly Patients with COVID-19
    Pamart, D.
    Otekpo, M.
    Asfar, M.
    Duval, G.
    Gautier, J.
    Annweiler, Cedric
    JOURNAL OF NUTRITION HEALTH & AGING, 2021, 25 (10): : 1140 - 1144
  • [8] Prealbumin: A New Biomarker for Predicting Prognosis in Patients with Severe COVID-19
    Issever, Kubilay
    Genc, Ahmed Cihad
    Cekic, Deniz
    Yildirim, Ilhan
    Genc, Ahmed Bilal
    Yaylaci, Selcuk
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2021, 31 (07): : S99 - S103
  • [9] Evaluation of the relationship of serum vitamin D levels in COVID-19 patients with clinical course and prognosis
    Kerget, Bugra
    Kerget, Ferhan
    Kiziltunc, Ahmet
    Kocak, Abdullah Osman
    Araz, Omer
    Yilmazel Ucar, Elif
    Akgun, Metin
    TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX, 2020, 68 (03): : 227 - 235
  • [10] Cardiac Biomarker Abnormalities Are Closely Related to Prognosis in Patients with COVID-19
    Tuo, Hu
    Li, Wenjing
    Tang, Lizhen
    He, Bing
    Yao, Baozhen
    Mao, Ping
    Tang, Qizhu
    INTERNATIONAL HEART JOURNAL, 2021, 62 (01) : 148 - 152